Tyrosinaemia screening implemented in England
Tyrosinaemia screening implemented in England
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
Bursary winners encourage other screening professionals to look into studying master's level health screening module.
The UK National Screening Committee held a horizon scanning event in Edinburgh to explore potential developments in research, international policy making and emerging technologies related to bowel cancer screening.
The UK NSC has held the inaugural meeting of the partnership board which will oversee the development of the in-service evaluation of newborn screening for spinal muscular atrophy in real world NHS services.
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes
The UK NSC has updated its guidance and processes for individuals working with the committee to declare any interests that may conflict, or be perceived to conflict, with that work.
There were nearly 290,000 separate visits to the UK NSC's 3 online platforms during 2023, reflecting the committee's ongoing commitment to continually improve its stakeholder engagement.
The UK NSC has endorsed the use of digital pathology as an alternative option to light microscopy for the review of cancer screening histopathology slides.
Three chapters added to UK NSC screening in healthcare manual which gives an overview of best practice for implementing health screening programmes anywhere in the world.
UK NSC survey results give big thumbs-up to blog and constructive feedback on web pages.
Nearly 100 people logged on to the second UK NSC web-based seminar, which focused on planning and implementing an in-service evaluation.